STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC (EIN 510629988) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

DIPNARINE MAHARAJ MD

Phone

5617525522

Tax Period

2023-01-01 to 2023-12-31

STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC, founded in 2007, is a micro nonprofit in the Medical Research sector that reported $15K in total revenue in fiscal year 2023. Revenue decreased 19% compared to the prior year. Expenses of $37K exceeded revenue, resulting in a 152% operating deficit.

Mission

THE ORGANIZATION IS TO BE OPERATED FOR SCIENTIFIC AND EDUCATIONAL PURPOSES TO CONDUCT RESEARCH TO UNCOVER THE MOLECULAR BASIS OF CANCER AND DEGENERATIVE DISEASE WITH THE EMPHASIS ON CANCER INCLUDING MULTIPLE MYELOMA AND OTHER CHRONIC DISEASES INCLUDING FRAILTY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $10,194

Program Service Revenue $0

Investment Income $4,320

Other Revenue $0

TOTAL REVENUE $14,514

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $36,198

Other Expenses $36,558

TOTAL EXPENSES $36,558

Year-over-Year Comparison

	2023	2022	Change
Revenue	$14,514	$18,013	-0.2%
Expenses	$36,558	$94,674	-0.6%
Net Income	$-22,044	$-76,661	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SUSAN MAHARAJ	DIRECTOR	1.00	Director	$0	$0	$0
DANIEL MANGRU	DIRECTOR	1.00	Director	$0	$0	$0
DIPNARINE MAHARAJ MD	PRESIDENT, D	6.00	Officer Director	$0	$0	$0
JACQUELINE GOUVEA MD	SECRETARY, T	4.00	Officer Director	$0	$0	$0
CLAUDIA OLIVEIRA	DIRECTOR	1.00	Director	$0	$0	$0
RICHARD SIMON	DIRECTOR	1.00	Director	$0	$0	$0
TYLER SMILEY	DIRECTOR	1.00	Director	$0	$0	$0
TERRELL W WITCHER	DIRECTOR	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$14,514	$36,558	$559,018	$-22,044
2022	$18,013	$94,674	$580,762	$-76,661
2021	$240,841	$275,836	$656,469	$-34,995
2020	$227,703	$340,717	$690,314	$-113,014
2019	$754,887	$328,726	$802,237	$426,161
2018	$129,690	$70,834	$375,301	$58,856

STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC